Lisa brings more than 17 years of healthcare communications expertise, advising clients from big pharma to small/mid-sized biotech to medical device and health tech companies, covering therapy areas including oncology, neuroscience, immunology, rare disease, infectious disease, women’s health, cardiometabolic diseases, and more.

Her background and strengths lie in corporate and product communications (global/US, with a particular focus on data and regulatory milestones), crisis and issues management, executive visibility/thought leadership, and internal communications/employee engagement.

Before joining Brunswick, Lisa worked on the Corporate Affairs team at Regeneron Pharmaceuticals. Prior to that, she advised clients at various healthcare communications agencies in New York City, including Real Chemistry, Syneos Health, Porter Novelli, and more recently at Weber Shandwick leading the Novartis business, where she also worked short-term out of their Tokyo office in Japan. Lisa speaks Spanish, Japanese and Portuguese, and graduated magna cum laude from Harvard University.